PTK2 and small cell lung carcinoma: These findings underscore the importance of alternative splicing in SCLC and the accuracy of the tool rMATS.54 We showed that FAK splicing alternatives were present in 119 (77.3%) of the 154 SCLCs, mainly in the SCLC-A, SCLC-N, and SCLC-P subtypes.